Combigene (Sweden) Today
| COMBI Stock | SEK 2.36 0.20 7.81% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Combigene is selling for under 2.36 as of the 26th of November 2024; that is 7.81 percent decrease since the beginning of the trading day. The stock's lowest day price was 2.36. Combigene has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Combigene AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of May 2024 and ending today, the 26th of November 2024. Click here to learn more.
CombiGene AB engages in the development and commercialization of gene therapy for the treatment of neurological and psychiatric disorders. CombiGene AB was founded in 1999 and is headquartered in Lund, Sweden. Combigene operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. The company has 19.8 M outstanding shares. More on Combigene AB
Moving against Combigene Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Combigene Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Combigene's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Combigene or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Combigene AB (COMBI) is traded on Stockholm Exchange in Sweden and employs 11 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 165.53 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Combigene's market, we take the total number of its shares issued and multiply it by Combigene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Combigene AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 19.8 M outstanding shares.
Combigene AB has accumulated about 34.09 M in cash with 22.11 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72.
Check Combigene Probability Of Bankruptcy
Ownership AllocationCombigene holds a total of 19.8 Million outstanding shares. Combigene AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Combigene Ownership Details
Combigene AB Risk Profiles
Although Combigene's alpha and beta are two of the key measurements used to evaluate Combigene's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.28 | |||
| Semi Deviation | 5.81 | |||
| Standard Deviation | 7.81 | |||
| Variance | 60.96 |
Combigene Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Combigene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Combigene Corporate Management
Elected by the shareholders, the Combigene's board of directors comprises two types of representatives: Combigene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Combigene. The board's role is to monitor Combigene's management team and ensure that shareholders' interests are well served. Combigene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Combigene's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jan Nilsson | Chief Officer | Profile | |
| Louise Aspenberg | Chief Officer | Profile | |
| Associate Woldbye | Scientific Founder | Profile | |
| Pr Kokaia | Scientific Founder | Profile | |
| Karin Agerman | Chief Officer | Profile | |
| Peter Ekolind | Chief Officer | Profile |
Additional Tools for Combigene Stock Analysis
When running Combigene's price analysis, check to measure Combigene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Combigene is operating at the current time. Most of Combigene's value examination focuses on studying past and present price action to predict the probability of Combigene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Combigene's price. Additionally, you may evaluate how the addition of Combigene to your portfolios can decrease your overall portfolio volatility.